Galfione Sarah K, Ro Jae Y, Ayala Alberto G, Ge Yimin
Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Medical College of Cornell University Houston, TX, USA.
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2536-43. eCollection 2014.
Vascular lesions are commonly encountered in routine pathologic practice and often pose diagnostic challenges owing to their morphologic diversity. Although WT-1 expression was reported in some vascular tumors, little is known about its staining patterns in a spectrum of vascular lesions from various locations. We examined WT-1 immunostain in 95 cases of vascular lesions including angiosarcomas (AS, 19 cases), hemangioendotheliomas (HE, 5), Kaposi's sarcomas (KS, 4), cavernous hemangiomas (CVH, 12), capillary hemangiomas (CPH, 7), pyogenic granulomas (PG, 4), lymphangiomas (LA, 4), hemangiopericytomas (HP, 5), glomus tumors (GT, 8), vascular malformation (VM, 13) and granulation tissue (GRT, 14). Strong WT-1 cytoplasmic stain was invariably observed in all cases of malignant and borderline vascular tumors including AS (19/19), KS (4/4) and HE (5/5). WT-1 was also consistently expressed in CPH (7/7), PG (4/4), and GRT (14/14), while it became weaker in VM (10/13) and often negative in CVH (2/12) and LA (0/4). WT1 stain was not demonstrated in HP (0/5) and rarely in GT (2/8). We conclude that consistent and diffuse WT-1 cytoplasmic stain in AS, HE and KS can be useful in distinguishing these tumors from poorly differentiated tumors with mimicking features. On the other hand, reliable WT-1 stain in CPH, PG and GRT may help in differential diagnosis with non-endothelial vascular tumors such as GT and HP. Recognizing the WT-1 cytoplasmic stain in a broad spectrum of benign and neoplastic tissues is critical in formulating appropriate immunohistochemical panels and avoiding misinterpretation of results.
血管性病变在常规病理实践中很常见,由于其形态学多样性,常常带来诊断挑战。尽管有报道称WT-1在一些血管肿瘤中表达,但对于其在来自不同部位的一系列血管性病变中的染色模式知之甚少。我们检测了95例血管性病变的WT-1免疫染色,包括血管肉瘤(AS,19例)、血管内皮瘤(HE,5例)、卡波西肉瘤(KS,4例)、海绵状血管瘤(CVH,12例)、毛细血管瘤(CPH,7例)、化脓性肉芽肿(PG,4例)、淋巴管瘤(LA,4例)、血管外皮细胞瘤(HP,5例)、血管球瘤(GT,8例)、血管畸形(VM,13例)和肉芽组织(GRT,14例)。在所有恶性和交界性血管肿瘤病例中,包括AS(19/19)、KS(4/4)和HE(5/5),均始终观察到强WT-1细胞质染色。WT-1在CPH(7/7)、PG(4/4)和GRT(14/14)中也持续表达,而在VM中表达变弱(10/13),在CVH(2/12)和LA(0/4)中常为阴性。在HP(0/5)中未显示WT1染色,在GT中很少显示(2/8)。我们得出结论,AS、HE和KS中一致且弥漫的WT-1细胞质染色有助于将这些肿瘤与具有相似特征的低分化肿瘤区分开来。另一方面,CPH、PG和GRT中可靠的WT-1染色可能有助于与非内皮性血管肿瘤如GT和HP进行鉴别诊断。认识到WT-1细胞质染色在广泛的良性和肿瘤性组织中的情况对于制定合适的免疫组织化学检测组合以及避免结果的错误解读至关重要。